Use of GLP-1 Agonist is Associated with Improvement in Mortality Rates in ESKD Patients

Download

Poster Presentation at American Heart Association Scientific Sessions 2025

Steph Karpinski, MS, MA; Terrence Bjordahl, MD; Rizwan Qazi, MD; Scott Sibbel, PhD, MPH; Eric Weinhandl, PhD, MS; Francesca Tentori, MD, MS; Steven M. Brunelli, MD, MSCE